Wu HL - Search Results

1

Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.

Su YD, Ma R, Fu YB, Wu HL, Liang XL, Liu YT, Yu Y, Yang ZR, Li Y. Su YD, et al. Among authors: wu hl. J Surg Oncol. 2024 Aug 25. doi: 10.1002/jso.27847. Online ahead of print. J Surg Oncol. 2024. PMID: 39183488

2

NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine.

Wu HL, Yang ZR, Yan LJ, Su YD, Ma R, Li Y. Wu HL, et al. World J Surg Oncol. 2022 Apr 30;20(1):141. doi: 10.1186/s12957-022-02604-3. World J Surg Oncol. 2022. PMID: 35490253 Free PMC article. Review.

3

Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study.

Yang ZR, Su YD, Ma R, Wu HL, Li Y. Yang ZR, et al. Among authors: wu hl. Front Oncol. 2022 Jul 1;12:811800. doi: 10.3389/fonc.2022.811800. eCollection 2022. Front Oncol. 2022. PMID: 35847956 Free PMC article.

4

Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases.

Wu HL, Yang ZR, Su YD, Ma R, Du XM, Gao Y, Li Y. Wu HL, et al. World J Surg Oncol. 2022 Oct 24;20(1):350. doi: 10.1186/s12957-022-02811-y. World J Surg Oncol. 2022. PMID: 36280841 Free PMC article.

5

Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study.

Yang R, Su YD, Liu G, Yu Y, Li XB, Zhao X, Ji ZH, Ma R, Yang ZR, Lin YL, Wu HL, Li Y. Yang R, et al. Among authors: wu hl. Int J Hyperthermia. 2023;40(1):2182749. doi: 10.1080/02656736.2023.2182749. Int J Hyperthermia. 2023. PMID: 36889694 Free article.

6

Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Su YD, Zhao X, Ma R, Fu YB, Yang ZR, Wu HL, Yu Y, Yang R, Liang XL, Du XM, Chen Y, Li Y. Su YD, et al. Among authors: wu hl. Int J Hyperthermia. 2023;40(1):2223374. doi: 10.1080/02656736.2023.2223374. Int J Hyperthermia. 2023. PMID: 37348853 Free article. Clinical Trial.

7

Etiological analysis of infection after CRS + HIPEC in patients with PMP.

Yang R, Zhao X, Fu YB, Lin YL, Ma R, Su YD, Wu HL, Liang XL, Li Y. Yang R, et al. Among authors: wu hl. BMC Cancer. 2023 Sep 26;23(1):903. doi: 10.1186/s12885-023-11404-1. BMC Cancer. 2023. PMID: 37752468 Free PMC article.

8

Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.

Lin YL, Zhu JQ, Ma RQ, Meng W, Wang ZY, Li XB, Ma R, Wu HL, Xu HB, Gao Y, Li Y. Lin YL, et al. Among authors: wu hl. Mol Cancer Res. 2024 Jan 2;22(1):70-81. doi: 10.1158/1541-7786.MCR-22-0801. Mol Cancer Res. 2024. PMID: 37768171

9

Long-term survival in patients with PMP: a single-institutional retrospective study from China.

Yang R, Fu YB, Li XB, Ma R, Su YD, Wu HL, Liang XL, Li Y. Yang R, et al. Among authors: wu hl. World J Surg Oncol. 2023 Oct 28;21(1):347. doi: 10.1186/s12957-023-03232-1. World J Surg Oncol. 2023. PMID: 37891655 Free PMC article.

10

Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.

Chen Y, Du X, Gao Y, Wu H, Zhao H, Su Y. Chen Y, et al. Cancer Control. 2023 Jan-Dec;30:10732748231220805. doi: 10.1177/10732748231220805. Cancer Control. 2023. PMID: 38092371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,144 results

Search Page

Filters